|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-5-18
|
|
pubmed:abstractText |
To assess the bioquivalence of carbamazepine (CBZ) controlled release formulation A (Tegretol CR, local) vs formulation B (Tegretol CR, Basel) and confirm their controlled release characteristics by comparing with conventional formulation (Tegretol).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0004-5772
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
886-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10778658-Administration, Oral,
pubmed-meshheading:10778658-Adult,
pubmed-meshheading:10778658-Biological Availability,
pubmed-meshheading:10778658-Carbamazepine,
pubmed-meshheading:10778658-Chromatography, High Pressure Liquid,
pubmed-meshheading:10778658-Cross-Over Studies,
pubmed-meshheading:10778658-Delayed-Action Preparations,
pubmed-meshheading:10778658-Humans,
pubmed-meshheading:10778658-Male,
pubmed-meshheading:10778658-Therapeutic Equivalency
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
|
|
pubmed:affiliation |
Novartis India Limited, Goregaon (E), Mumbai.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
